Your browser doesn't support javascript.
loading
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.
Lam, P Y; Ru, Y; Jadhav, P K; Aldrich, P E; DeLucca, G V; Eyermann, C J; Chang, C H; Emmett, G; Holler, E R; Daneker, W F; Li, L; Confalone, P N; McHugh, R J; Han, Q; Li, R; Markwalder, J A; Seitz, S P; Sharpe, T R; Bacheler, L T; Rayner, M M; Klabe, R M; Shum, L; Winslow, D L; Kornhauser, D M; Hodge, C N.
  • Lam PY; DuPont Merck Pharmaceutical Company, DuPont Merck Experimental Station, Wilmington, Delaware 19880-0500, USA. lampy@carbon.dmpc.com
J Med Chem ; 39(18): 3514-25, 1996 Aug 30.
Article en En | MEDLINE | ID: mdl-8784449
Search on Google
Banco de datos: MEDLINE Asunto principal: Urea / Inhibidores de la Proteasa del VIH Límite: Animals / Humans Idioma: En Año: 1996 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Urea / Inhibidores de la Proteasa del VIH Límite: Animals / Humans Idioma: En Año: 1996 Tipo del documento: Article